- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05143684
Maternal Lateral Tilt and Cardiac Output in Caesarean Section
Impact of Maternal Lateral Tilt on Cardiac Output During Caesarean Section Under Spinal Anaesthesia: A Prospective Observational Study
Background: Left uterine displacement (LUD) has been questioned as an effective strategy to prevent aortocaval compression after spinal anesthesia (SA) for cesarean delivery (CD). The investigators tested if LUD has a significant impact on cardiac output (CO) in patients undergoing CD under SA during continuous non-invasive hemodynamic monitoring.
Methods: Forty-six patients were included in the final analysis. The investigators considered 4 timepoints of 5 minutes each: T1=baseline with LUD; T2=baseline without LUD; T3=after SA with LUD; T4=after SA without LUD. LUD was then repositioned for CD. Primary outcome was to test if CO decreased from T3 to T4. We also compared CO between T1 and T2 and other hemodynamic variables: mean, systolic and diastolic blood pressure (respectively MAP, SAP and DAP), heart rate (HR), stroke volume (SV), stroke volume variation (SVV), pulse pressure variation (PPV), contractility (dP/dt), dynamic arterial elastance (Eadyn) at the different timepoints. Data on fetal Apgar scores and umbilical arterial and venous pH were collecte
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary outcome was to test if CO decreases significantly after LUD removal in patients under SA for CD. This is a prospective observational study.
Data were gathered from pregnant patients who, in addition to standard monitoring, underwent perioperative non-invasive hemodynamic monitoring by ClearSight system on the Edwards Lifesciences HemoSphere platform (Edwards Lifesciences, Irvine, CA).
The parameters were recorded at 20 seconds-intervals. The investigators considered 4 timepoints. T1 were the baseline values recorded for 5 minutes, after initial stabilization of parameters, with the patient laying down on the operating table with LUD. At T2, LUD was removed and we considered for the analysis hemodynamic data of the subsequent 5 minutes. The investigators indicated as T3 the 5 minutes following SA with a satisfactory sensory block and as T4 the subsequent 5 minutes following LUD removal. Figure 1 summarizes the timepoints of our analysis. LUD was accomplished by positioning a wooden wedge wrapped with cotton, to make it comfortable, and medical sheets with a measured angle of 15° under the right flank of the laying down patient. In all patients, after T4 the 15° wooden wedge was positioned again and surgery was performed with LUD.
Anesthesia was standard spinal procedure, fluid management was left to the attending anesthesiologist.
The attending anesthesiologist was blinded to the advanced hemodynamic parameters from the ClearSight system except for the continuous BP values. The investigators defined hypotension as an absolute value of MAP < 65 mmHg. This value was considered as trigger for the attending anesthesiologist for the administration of norepinephrine 5 mcg. Norepinephrine boluses were repeated to reach a MAP>65mmHg. Bradycardia was defined as a heart rate of < 60 bpm. Atropine 0.5 mg was administered for the treatment of bradycardia combined with hypotension, or for an absolute value of heart rate < 45 bpm. After delivery, Oxytocin was administered to facilitate the uterine contraction.
We also evaluated the impact of maternal blood pressure and CO on fetal outcome collecting neonatal Apgar scores at 1 and 5 minutes after birth, and umbilical cord arterial and venous pH.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Rome, Italy, 00168
- IRCCS Fondazione Policlinico Universitario Agostino Gemelli
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- pregnant patients at term (36th to 40th week of gestation) scheduled for elective caesarean section under spinal anesthesia.
Exclusion Criteria:
- age <18 years
- American Society of Anesthesiologists score >3
- cardiac arrhythmias or aortic regurgitation
- pregnancy-induced hypertension
- pre-eclampsia
- body mass index (BMI) > 35 kg/m2
- foetal complications
- coagulation disorders or contraindication to neuraxial block
- emergency surgery
- preoperative infection
- patient's refusal
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac Output (l/min) measured by non-invasive hemodynamic monitoring
Time Frame: at 5 minutes from left lateral uterine tilt removal under spinal anesthesia
|
Does cardiac output decrease significantly after left lateral uterine displacement removal in patients under spinal anesthesia for caesarean delivery?
|
at 5 minutes from left lateral uterine tilt removal under spinal anesthesia
|
Collaborators and Investigators
Investigators
- Study Director: Gaetano A Draisci, MD, IRCCS Fondazione Policlinico Universitario Agostino Gemelli
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LUD-CS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypotension Drug-Induced
-
Damanhour Teaching HospitalRecruitingHypotension Drug-InducedEgypt
-
Damanhour Teaching HospitalCompletedHypotension Drug-InducedEgypt
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingHypotension Drug-Induced | Hypotension During Surgery
-
Universidad Industrial de SantanderCompletedHypotension Drug-InducedColombia
-
Nicholaos C Bellos, MDGlaxoSmithKlineCompletedDrug-induced Hypotension
-
Dalian Municipal Central HospitalRecruitingHypotension Drug-InducedChina
-
Fayoum University HospitalRecruitingHypotension Drug-InducedEgypt
-
Assiut UniversityUnknown
-
Assiut UniversityUnknown
-
Medical University of GrazRecruiting
Clinical Trials on Left Lateral Uterine Displacement
-
Hartford HospitalUnknown
-
Changhai HospitalCompleted
-
Ewha Womans University Mokdong HospitalSeoul St. Mary's Hospital; Pusan National University Hospital; Chonnam National... and other collaboratorsUnknown
-
Hanyang University Seoul HospitalCompletedCardiac ArrestKorea, Republic of
-
National Cheng-Kung University HospitalRecruitingPelvic Organ Prolapse | Uterine ProlapseTaiwan
-
Maastricht University Medical CenterUniversity Medical Center Groningen; UMC Utrecht; Erasmus Medical Center; Academisch... and other collaboratorsCompletedColorectal Cancer | Liver Disease | Liver MetastasisNetherlands
-
Assiut UniversityUnknownHeart Defects, CongenitalEgypt
-
Kafkas UniversityCompleted
-
Cairo UniversityUnknownCesarean Section Complications | Spinal Anesthetic ComplicationsEgypt
-
Acibadem UniversityCompleted